DENTSPLY SIRONA INC.

Two shareholders are on record for DENTSPLY SIRONA Inc. as of 4 September 2026: Vanguard Group Inc, holding 13.05% of ordinary shares, and iShares Trust – iShares Core S&P Mid-Cap ETF, holding 3.80%. Both interests are recorded as direct holdings of ordinary stock, and no other share class is indicated in the available record.

DENTSPLY SIRONA Inc. is a Nasdaq-listed company (ticker: XRAY) with 200,320,502 shares outstanding as of April 2026, according to its 2026 annual meeting proxy statement, so the two holdings shown here represent only the largest reportable positions rather than the company’s complete shareholder base. Vanguard Group Inc’s status as a holder of DENTSPLY SIRONA Inc. common stock is corroborated by Schedule 13G filings it has made with the U.S. Securities and Exchange Commission, though the exact percentage in those filings can differ from this record depending on the filing date used.

Both disclosed shareholders are asset managers or investment funds rather than natural persons, so no Ultimate Beneficial Owner can be identified from this information; establishing one would require tracing beneficial interests in the underlying investment funds themselves, which is not disclosed here.

This disclosure should be treated as major-shareholders-only: for a widely held, exchange-listed U.S. company such as this, only holders whose stakes cross regulatory reporting thresholds are typically identified, and numerous smaller institutional and retail holders are not reflected in this overview.

DENTSPLY SIRONA Inc.’s register lists 22 officers in total, of which 5 appear on this profile, all shown with active work status as of the register’s most recent sync. Independent verification against the company’s U.S. Securities and Exchange Commission filings shows that several senior roles have changed since that underlying data was captured, so the individuals shown here for Chief Executive Officer, Chief Financial Officer and General Counsel should not be treated as the company’s current post-holders.

Three verified recent changes: Daniel T. Scavilla was appointed President and Chief Executive Officer of DENTSPLY SIRONA Inc. effective 1 August 2025, succeeding Simon D. Campion, who left the company on 31 July 2025 and also stepped down from its board, according to an SEC Form 8-K filed on 21 July 2025. John Fortson was appointed Executive Vice President and Chief Financial Officer effective 20 July 2026, per an SEC filing dated 11 June 2026. Richard C. Rosenzweig ceased to serve as an executive officer, stepping down from his role as Senior Vice President, Corporate Development, General Counsel and Secretary, effective 3 October 2025, and transitioned to a non-executive Special Legal Advisor position, per an SEC Form 8-K filed on 2 October 2025.

Nationality is not disclosed for any officer in the available record, and no corporate officers are recorded for this company. The underlying registry data should be treated as a point-in-time snapshot that can lag official company announcements, particularly for recent leadership changes such as those described above.

DENTSPLY SIRONA Inc. sits at the top of its own corporate group. No parent company is recorded for it in the register, and this is consistent with its status as a Nasdaq-listed, publicly traded company (ticker: XRAY) with no corporate parent identified in its own U.S. Securities and Exchange Commission filings.

The register shows 61 subsidiaries recorded beneath DENTSPLY SIRONA Inc. across 23 jurisdictions, nine of which have their own further recorded subsidiaries. This is broadly consistent with, though not identical to, the list of significant subsidiaries DENTSPLY SIRONA Inc. filed with the SEC as Exhibit 21.1 to its Form 10-K for the year ended 31 December 2024, which named 137 subsidiaries spanning the United States, Germany, France, Sweden, the United Kingdom, Switzerland, the Netherlands, China, Mexico and more than a dozen other jurisdictions. Ownership percentages are not disclosed for most entries in the register; the SEC exhibit separately identifies one subsidiary, Dentsply Sirona (Phils.), Inc. in the Philippines, as 99.999% owned rather than wholly owned.

The subsidiary count and jurisdiction list shown in the register should be treated as partial rather than exhaustive: it reflects entities for which shareholder filings have actually been made with the relevant national registers, so subsidiaries in jurisdictions without such filings, or omitted from the official SEC exhibit, will not necessarily appear in either source.